ACTRN12610000874011已完成2 期
An investigator blinded controlled study of the nasal application of 5% tea tree oil (TTO) versus mupirocin for the prevention of catheter-associated infections in renal dialysis patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Haemodialysis or peritoneal dialysis planned
排除标准
- •Known sensitivity to tea tree oil
- •Use of medicated and non-medicated nasal ointments in the past 12 weeks
- •Serious, uncontrolled disease (including serious psychological disorders) likely to interfere with the study and/or likely to cause death within the study duration
- •Acute renal failure
研究者
相似试验
进行中（未招募）
1 期
Clinical trial MV-CHIK-205 is designed to investigate the safety, tolerability, and long-term immunogenicity of a novel vaccine designed to protect against chikungunya virus, a mosquito-borne pathogen causing chikungunya fever throughout tropical areas worldwide.The study is being conducted in healthy volunteers for the prophylaxis of chikungunya virus (CHIKV) infection.EUCTR2018-000211-25-GBThemis Bioscience GmbH60
进行中（未招募）
不适用
A randomised assessor blinded study to examine the role of skin testing in the prediction of peri-operative anaphylaxis and its correlation with mast cell tryptase and total IgE. - Peri-operative screening for sensitization to NMDAsPrevalance of sensitivity of immune system to the four named neuromuscular blocking drugs in patients undergoing anaesthesia.EUCTR2005-001622-91-GBRoyal Group Hospitals160
进行中（未招募）
不适用
An Investigator-blind, Controlled Study to Assess the Efficacy of Five Distinct Combinations of LAS 41004 in Different Concentrations Compared to Placebo and to Two Active Controls in a Psoriasis-Plaque-TestEUCTR2010-018355-10-DEAlmirall Hermal GmbH
进行中（未招募）
不适用
An Investigator-blind, Controlled Study to Assess the Efficacy and Safety of different formulations of LAS 41004 Compared to Placebo and to Active Control in a Psoriasis-Plaque-TestEUCTR2010-022281-27-DEAlmirall Hermal GmbH
进行中（未招募）
不适用
Efficacy and Safety of different formulations of LAS 41004 compared to active control and placeboPlaque-type psoriasis (psoriasis vulgaris) for at least 12 monthsMedDRA version: 13.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-000186-13-DEAlmirall Hermal GmbH